Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Tacrovera Solution

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Tacrolimus (0.1% w/v)

Overview Tacrovera Solution

Eczema (atopic dermatitis) is treated with Tacrovera Solution, which reduces inflammation (skin redness and swelling) by modulating specific immune cell activity. This eases itching and improves atopic dermatitis rashes. Applied externally, Tacrovera Solution should be gently and evenly rubbed into affected skin 2-4 times daily, or as directed by a physician. Avoid overuse and bandages/plasters over treated areas. Report lack of improvement after two weeks or worsening skin condition to your doctor. Common side effects may include redness, headache, folliculitis, and application site reactions (burning, irritation, itching, redness). Use during pregnancy or breastfeeding is generally not advised unless medically necessary.

Uses of Tacrovera Solution

Managing atopic dermatitis

Major Benefits of Tacrovera Solution:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always refer to the product label for proper administration guidelines.

Common Side effects of Tacrovera Solution:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacrovera Solution:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always consult the product label for usage guidelines.

How Tacrovera Solution works:

Tacrovera Solution, an immunosuppressive agent, reduces the activity of specific immune cells responsible for cutaneous inflammation, thereby alleviating itching and improving the appearance of rashes characteristic of atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No drug interaction detected.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tacrovera Solution during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Tacrovera Solution without significant risk to their infants. Available human data indicates minimal potential harm to the baby.

DrivingDrivingNone

No drug interaction identified.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No drug interaction identified.

What if you forget to take Tacrovera Solution :

Should you forget a dose of Tacrovera Solution, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen.

Facts to Know About Tacrovera Solution

LabelValue
Type of Compound Macrocyclic lactones
Potential for Dependence None.
Medication Classification Cancer-fighting drugs
Mechanism of Action Drugs suppressing the immune system: Calcineurin inhibitors

FAQs on Tacrovera Solution

Tacrovera Solution is an immunomodulatory medication that primarily reduces immune system activity. It's indicated for adults with moderate to severe atopic dermatitis (eczema) who haven't responded to, or experience adverse effects from, steroid treatments. Atopic dermatitis involves an overactive skin immune response, resulting in inflammation, itching, redness, and dryness. Tacrovera Solution modifies this aberrant immune reaction, thereby alleviating inflammation and itching.
Topical application of Tacrovera Solution may induce localized skin reactions, including irritation, burning, and pruritus. These effects are typically mild to moderate and usually subside within seven days of treatment initiation. Erythema is frequently observed, accompanied by warmth, discomfort, paresthesia, and rash at the application site. Treatment use elevates the likelihood of folliculitis, herpes labialis, acne, and disseminated herpes simplex infections.
Tacrovera Solution offers a safe and effective short-term approach to managing atopic dermatitis, exhibiting superior safety compared to other immunosuppressants. Topical application minimizes systemic absorption, resulting in fewer side effects than oral administration.
Tacrovera Solution is not a controlled substance and does not present a risk of misuse. Controlled substances, by definition, have abuse potential, requiring authorization from both medical professionals and regulatory bodies for dispensing.
Prolonged application of Tacrovera Solution is associated with a heightened risk of lymphomas, a type of lymph node cancer. Limited research indicates a link between Tacrovera Solution ointment, or comparable treatments, and the development of skin cancer or lymphoma in a small number of patients. Seek medical advice if Tacrovera Solution ointment is needed for over six weeks, or if your eczema shows no improvement or worsens during treatment.
Tacrovera Solution is a non-steroidal medication that regulates immune system function. It's employed in eczema treatment, particularly atopic dermatitis. A key benefit is its avoidance of skin thinning or other adverse effects typical of steroids.
Tacrovera Solution
575
MRP 700
17% off